Fed. Circ. Backs Sequenom Bid To Bar Ariosa Prenatal Test
The Federal Circuit on Friday gave Sequenom Inc. another chance to obtain a preliminary injunction on an Ariosa Diagnostics Inc. prenatal blood test it claims infringe its patent, finding that a...To view the full article, register now.
Already a subscriber? Click here to view full article